The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery
Ann Surg
.
2017 Dec;266(6):e61-e62.
doi: 10.1097/SLA.0000000000001502.
Authors
Nikolaos Kamperidis
1
,
Omar Faiz
,
Naila Arebi
Affiliation
1
St Mark's Hospital, Harrow, London, UK.
PMID:
29136975
DOI:
10.1097/SLA.0000000000001502
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Inflammatory Bowel Diseases*
Infliximab
Postoperative Period
Tumor Necrosis Factor-alpha*
Substances
Tumor Necrosis Factor-alpha
Infliximab